Between evidence and allegation: factual accuracy in discussions on fluoride toxicity and research integrity - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Navigating Claims and Evidence: Assessing the Truthfulness of Fluoride Toxicity Discussions and Research Validity

  • By

  • Andrea Buettner

  • Patrick Diel

  • Gerhard Eisenbrand

  • Bernd Epe

  • Petra Först

  • Tilman Grune

  • Sabine Guth

  • Dirk Haller

  • Volker Heinz

  • Michael Hellwig

  • Hans-Ulrich Humpf

  • Henry Jäger

  • Sabine E. Kulling

  • Alfonso Lampen

  • Marcel Leist

  • Angela Mally

  • Doris Marko

  • Ute Nöthlings

  • Elke Röhrdanz

  • Angelika Roth

  • Joachim Spranger

  • Stefan Vieths

  • Wim Wätjen

  • Jan G. Hengstler

  • September 1, 2026

Share

  • 1

    A 2020 review concluded that fluoride exposure at typical European levels does not support adverse health effects, including neurotoxicity.

  • 2

    Allegations against the authors of the review, including claims of industry influence, lack supporting evidence and are deemed false.

  • 3

    The German Research Foundation and its Senate Commission on Food Safety were inaccurately implicated in industry influence without evidence.

  • 4

    The European Food Safety Authority found insufficient evidence linking fluoride exposure to neurodevelopmental effects in 2025.

  • 5

    Both the EFSA and the German Federal Institute for Risk Assessment noted the need for further research on fluoride's biological activity.

Original Source(s)

Between evidence and allegation: factual accuracy in discussions on fluoride toxicity and research integrity

  • by Andrea Buettner, Patrick Diel, Gerhard Eisenbrand, Bernd Epe, Petra Först, Tilman Grune, Sabine Guth, Dirk Haller, Volker Heinz, Michael Hellwig, Hans-Ulrich Humpf, Henry Jäger, Sabine E. Kulling, Alfonso Lampen, Marcel Leist, Angela Mally, Doris Marko, Ute Nöthlings, Elke Röhrdanz, Angelika Roth, Joachim Spranger, Stefan Vieths, Wim Wätjen, Jan G. Hengstler

  • September 1, 2026

Related Content

Grand challenge: building a digitally enabled one health future for pediatric infectious diseases

Do antihistamines help atopic dermatitis?

First-generation H1 antihistamines likely increase cognitive impairment, with cognitive effects differing among second-generation antihistamines.

HHS Convenes Leaders at the Live Real Life Symposium to Address Harms of Screen Use in Children